10
Mar

On the Road to Off-Road Profits!

Good Morning!

I think it’s time to say hello again (for those of you who’ve been with me awhile) to one of our past winners…

San West, Inc. (SNWT)

SNWT is a retailer of premier off-road recreational vehicles in Southern California and the Western United States as well as a leading supplier in the off-road recreational vehicle arena through aftermarket parts, accessories and its highly successful vehicle repair and maintenance center. continue

Category : Daily Soup | Blog Bookmark and Share
9
Mar

StemCells, Inc. (STEM) has been the poster child for the stem cell industry since late 2008.  It has made many people rich speculating on the ups and downs of this particular stock.  With its ticker symbol that seems to represent the entire industry, investors and traders have made this a very popular stock.

Their is an old saying that says “when the media sneezes, the whole world catches cold”.  That has certainly been a huge factor in the rise (and fall) of STEM and other stem cell stocks.  Stem cell hysteria has hit several times over the past few months with investor interest being peaked by media hype.

Here is a description of the company from Yahoo! Finance:  StemCells, Inc., a clinical-stage biotechnology company, focuses on the research, development, and commercialization of products derived from stem cell technologies. It focuses on developing cell-based therapeutics to treat diseases of the central nervous system and liver.

Most stem cell companies that I have seen are very far away from making their particular take on the propagation or use of stem cells profitable.  STEM is no different.  It does have some revenues, but expenses far outweigh revenues.  The good news for STEM is that management has used all of this hype and interest in stem cell stock pay dividends in the form of equity raises and fundraising.  STEM has an impressive cache of cash (over $28MM as of 9-30–09), but at a $7MM quarterly burn rate that cash will last them a year.  STEM will probably never seen penny stock land again and I could see it upgrading its listing in the future.

Chart analysis:

STEM has an interesting chart that bears watching.  See my annotations below.

stem

The stock appears to be basing at this level and performance of this stock could depend solely on what news comes out regarding stem cells in the next few weeks.

For those traders who want to be ready for the next stem cell explosion, here are some tickers that you should hold on to:

ACTC  * ALXN * AOLS * ARIA * ASTM * BHRT * BMSN * BTIM * CBAI * CCEL * CELG * CRIS * CUR * DNDN * GERN * IART * INCR * ISCO * KOOL * MCET * MEDS * OCHT * OSTE * OSIR * PKI * PPMD * PSTI * SPPI * STEM * VODG

I have previously blogged ACTC, ARIA, CBAI, PSTI and now STEM.

There is a strong short sentiment about STEM with the latest Yahoo! stats showing a short percentage of 15.6% as of 2-12-10

In my opinion, STEM has a nice setup.  Any strength in the stock and the short squeeze will only accelerate the gains.  The stock should be avoided on any break below the current support of $1.16

Good luck and good trading,

Jeffrey Dean

Editor

___________________________________________________________________________

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. Neither InvestorSoup.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Category : General Commentary | Blog Bookmark and Share
5
Mar

That will come crashing to earth soon!

MedCareers Group, Inc. (MCGI) has been a great story to watch over the past few days.  Lots of PR and a frothy stock price and some very impressive gains.  The question for me is it real and will it last?

It appears that it only became active recently after changing its name from RX Scripted, Inc. in early 2010.

They must have been saving up press releases because they have flooded the airwaves with several in rapid succession.  With the purchase of medcareers.com, they became Med Careers, Inc.  That book of business has been enhanced with the announcement of the purchase of two additional companies: Staff MD and workabroad.com.

It appears that they are in the online medical staffing business based upon the PR’s I’ve read.  The website gives some amorphous description of the business they are in. …that doesn’t really match their recent PR’s.

As you can tell, I am highly skeptical of their business. It seems like it is a phenomenon of some good PR and the expectation that this company is going to be a “player”.  The challenging thing is to put some kind of revenue and profits numbers to all this PR.  MCGI isn’t telling us, so I am assuming that the company is more sizzle than steak.

For as fuzzy as I think their website is, you can’t argue with this chart:

mcgiNote:  The issue is so new that my old charting standby, Stockcharts.com, hasn’t even listed MCGI in its database

Will this stock be a penny stock before it is a $5 stock?  I think so.

The Stochastics are very overbought, but until we get more trading history it is almost impossible to point to that indicator to say that it is going to fall.  What can they follow this hype up with?  Eventually traders will become numb to news about MCGI. Financial transparency, real revenues and profits will keep this stock afloat.  When the good news runs out, so will MCGI.

Good luck and good trading,

Jeffrey Dean

Editor

Oh, by the way:  The answer to the question I posed above (The question for me is it real and will it last?) is NO and NO!

Category : General Commentary | Blog Bookmark and Share
5
Mar

Americans are Keeping their Cars Longer and that’s Why GNAU (at just a dime a share) is Driving Down the Money Highway!

Good Morning!

Today’s alert company is:

General Automotive Company (GNAU) continue

Category : Daily Soup | Blog Bookmark and Share
4
Mar

Cord Blood America was one of my best picks for 2009 (not my best, but close).  I had correctly called its September move (as the chart below will indicate).  I think that it might be time to take another look at Cord Blood America, Inc. (CBAI). Here is a link to my earlier blog.

Truthfully, it has been flogged unmercifully in the penny stock press.  It has been hailed as everything from the next Genentech to the next Spongetech.  I think the truth is somewhere in the middle.

CBAI is a stock built on hype.  It really hasn’t proven that its business model can actually work.  My wife and I have 4 kids and after each birth we were given the opportunity to harvest cord blood.  We declined each time…too expensive, the value to our children wasn’t clear in our mind, logistics of storing and accessing it….a whole host of reasons.

Having said all this, I think that CBAI might actually make it….at least long enough for traders to make some money. I have been reading the press releases and the company is taking great pains to both dazzle and teach.  Glitzy Las Vegas-style openings are contrasted with PR’s that tell of debt extinguishments, agreements signed, alliances gained, etc…  The truth is that CBAI lives a hand-to-mouth existence.  It has little or no cash and negative cash flow.  Debt is less of a problem than it was in ‘09 with some debt being retired, but they are not “out of the woods”.

I think the chart is positive and if CBAI can catch fire, I would expect to see some strong gains.

Here is the chartcbai

CBAI seems to be consolidating at this level (as my chart indicates).    Any break below the current price of $.009 and the stock should be avoided.  I don’t believe that it will weaken, but, then again, my crystal ball is in the shop.

Good luck and good trading,

Jeffrey Dean

Editor

Category : General Commentary | Blog Bookmark and Share
4
Mar

eCrypt Technologies (ECRY) Prevents Hackers From Invading Your Privacy And Stealing Your Identity!

Good Morning!

Cyber crime is a profitable business. So profitable in fact that it’s surpassed illegal drug trafficking as a felon’s #1 moneymaker.

And wireless email users are a juicy and easy target.

· Wireless email users are expected to rise to 300 million this year

· Worldwide there’s 1 known hacker for every 15 wireless email users

· 10 million Americans will become victims of identity theft this year.

· An identity thief has only a 1 in 700 chance of being caught by law enforcement

· 70% of identity theft victims may never recover from damages to their credit rating

· 47% of identity theft victims may not be able to get a loan continue

Category : Daily Soup | Blog Bookmark and Share
2
Mar

Sirius XM Radio (SIRI) has made an almost miraculous comeback from irrelevancy (and penny stock land) over the past few months.  SIRI has seen its stock rise from the low $.50’s at the end of 2009 to a recent high of around $1.15 just a few days ago.  This was very good news for the company.  Since it was facing a NASDAQ delisting and with the stock trading above the magic $1.00 mark for a period of time, SIRI was thinking it was “scot-free”.  Think again.

Last week’s drop (and this week’s continuing drop) was not surprising given the overheated condition of the stock from all indicators.  It is not clear what effect short sellers had in the decline since the short squeeze had been on for many months with the advance of the stock price.  SIRI fought through all of those challenges….that is until now.

SIRI has one more chance to regain compliance with NASDAQ regs if it can trade above $1.00 for 10 consecutive days before the March 15th date imposed by the exchange.  I don’t see that happening.  The reverse split that has been discussed seems the only option now despite management’s contention that they will be able to get a variance on appeal.  NOT BLOODY LIKELY.

SIRI should have executed the reverse split when they were so strong late last year.  The market was really pumped on SIRI and its progress.  Institutions were buying and retail investors were very happy with the run-up.  Now with a delisting notice sure to come, short sellers will be circling SIRI like sharks looking for blood.  I think the short term outlook for SIRI is definitely bearish.

Here is a chart that shows what I mean.

siri2

Is SIRI a dead dog?  Will shorters drive this one right back down to 50 cents (or lower) again.  I don’t think so.  SIRI is in a “stew of its own making”, but I think will be a good stock to buy on dips.  Right now, I would hold off (unless you are shorting the stock).  The boards and investor sentiment are telling me that this one has farther to fall.  Retail investors might not like it when they do the reverse stock split, but IMO it is inevitable.

Do your own due diligence.  It continues to be a hot topic on the boards that I monitor and it is fun to read what people write.  Make up your own mind.

Good luck and good trading,

Jeffrey Dean

Editor-in-Chief

—————————————————————————————————————————————————

<!– /* Font Definitions */ @font-face {font-family:”Cambria Math”; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-1610611985 1107304683 0 0 159 0;} @font-face {font-family:Cambria; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-1610611985 1073741899 0 0 159 0;} /* Style Definitions */ p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:”"; margin:0in; margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:”Times New Roman”,”serif”; mso-fareast-font-family:”Times New Roman”;} .MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-size:10.0pt; mso-ansi-font-size:10.0pt; mso-bidi-font-size:10.0pt;} @page Section1 {size:8.5in 11.0in; margin:1.0in 1.25in 1.0in 1.25in; mso-header-margin:.5in; mso-footer-margin:.5in; mso-paper-source:0;} div.Section1 {page:Section1;} –>

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. Neither InvestorSoup.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Category : General Commentary | Blog Bookmark and Share
2
Mar

Most traders are familiar with…


BONANZA OIL & GAS, INC. (BGOI)


Over the past few months, BGOI has been in the news a lot—and rightly so!

The stock zoomed from 1 cent in mid-December to 7 cents in late January.

Then, the profit taking hit and the stock plummeted back down to around 1 cent again. And that’s were we are today!

It’s Déjà vu all over again!

continue

Category : Daily Soup | Blog Bookmark and Share
24
Feb

I must apologize first for not blogging on Monday and Tuesday, but I was on a ski trip with the family and not thinking about the markets.  My alert for Monday (BLGW) is doing very well I’m happy to report.

I jumped back in to my research this morning and came across a great company that has solid prospects:  Cytomedix, Inc., a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis:physiological process involving the growth of new blood vessels from pre-existing vessels).

GTF’s AutoloGel System utilizes a unique technology that enables rapid isolation and activation of platelet rich plasma (PRP) from a patient’s own blood. The PRP is subsequently processed to produce a gel for application to the wound bed, re-establishing a balance needed for natural healing to occur. AutoloGel contains growth factors, cytokines and chemokines that are essential for normal wound healing. The AutoloGel System is used at the point-of care and is the only PRP System indicated for use in exuding wounds such as leg ulcers, pressure ulcers, diabetic ulcers and for the management of mechanically or surgically-debrided wounds.  The AutoloGel System is the only PRP system that is FDA cleared for the care of wounds.

The company is generating revenues and those revenues are increasing significantly.  They have cash-in-the-bank and NO long term debt….always a positive sign for me.  With the 2009 capital raise, that bought the company some time to execute on their plan.  Based upon what I have seen, they have high expectations for their AutoloGel System.

The chart indicates that the stock is trading near the bottom of its most recent trading range.

  • After a steep selloff, the stock might be ready to run again
  • An Amex stock, GTF is trading at attractive levels
  • The strongest support is at 40 cents (see the chart)…. I don’t think it will drop that far, but it could

gtf

I am recommending that traders put GTF on their radar screens.  I think the downside risk is low, but the upside is strong.

As always, do your own due diligence.

Good luck and good trading,

Jeffrey Dean

Editor

Category : General Commentary | Blog Bookmark and Share
19
Feb

The last time I blogged Coates International, Ltd. (COTE) was to tell traders to short them (Read it here).  And, I was right.  I liked the company  fundamentally, but thought that the chart was setting it up for a fall.  COTE blazed a trail across the markets back in July of ‘09 almost tripling in value from around 40 cents to $1.15.  In my earlier blog, I said the following:  “The stock might be due for a correction in the near future.  Any kind of reasonable “support” for the stock is around the 50 cent mark….so, it could fall a long way!”

Three days later, the stock was at 53 cents! A penny stock, once again!

Now, the chart is turned around.  The stock price is depressed and I think that COTE should be watched for a bounce in the near term (and it could be the next hot stock if they start landing some contracts).

Let’s talk about the company:  COTE is the creator, developer and manufacturer of the patented Coates spherical rotary valve system (CSRV System) for use in various piston-driven internal combustion engines.  It is a technology that has been under development for over 15 years and may now be “ready for its closeup”.  The company is claiming that they have created the internal combustion engine of the future.  They claim significant benefits compared to the engines of today: Increased Engine Efficiency, Lower Emissions, Reduced Lubrication Requirements, Cheaper to Manufacture, and Adaptable to Multiple Fuel Types.  Here is a link to a very informative article done on COTE by Industry Online.  I am not an automotive engineer, but it sounds like COTE has something in their CSRV technology.

With the income of a Canadian sale for $10MM ($8 MM of which remains a receivable), its Chinese manufacturing initiatives and several Beta sites that are under negotiation, it might be a good time to put COTE on your trading radar.

The chart looks good for gains!

  • COTE is trading near its 52-week low ($0.28);
  • Watch to see if this level acts as support for the stock…any break below 32 cents should be watched to see if a new bottom develops;
  • The MACD is drifting….with good news and some buying, it could turn bullish very quickly.

cote

Another factor to consider about COTE that gives me comfort is the insider ownership.  I like the fact that insiders own over 80% of the company.  COTE hasn’t been an overnight sensation.  My impression is that they have a core group of founders and executives that believe in the mission of the company and are in for the long haul.  I hope they get rewarded, because that means I will be rewarded too.  I have put COTE on my own personal trading radar with the idea of buying shares in the very near future.  I have a call in to the company and will update my blog with any intelligence I gather.

Do your due diligence!

Good luck and good trading,

Jeffrey Dean

Editor-in-Chief

********************************************************************************************

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. Neither InvestorSoup.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Category : General Commentary | Blog Bookmark and Share

About Us

Traders make huge profits from penny stocks! Our Hot stock alerts are sent the second we identify likely stocks that we feel will fly! We are passionate about small caps, penny stocks and sub-penny stocks. We are the resource that you need to profit from penny stocks. Bookmark us and check back frequently. Read more »

Subscribe

Subsribe via RSS Feed Reader

Contact Us

InvestorSoup.com
4828 S. Broadway #182 | Tyler, TX 75703

Privacy Policy
close this